Anirudha Singh
Affiliations: | 2003-2008 | Polymer Science | University of Akron, Akron, OH, United States |
| 2015- | Urology | Johns Hopkins University, Baltimore, MD |
Google:
"Anirudha Singh"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhu W, Chu C, Kuddannaya S, et al. (2019) Imaging of Composite Hydrogel Scaffold Degradation Using CEST MRI and Two-Color NIR Imaging. Advanced Functional Materials. 29 |
| Faust HJ, Sommerfeld SD, Rathod S, et al. (2018) A hyaluronic acid binding peptide-polymer system for treating osteoarthritis. Biomaterials. 183: 93-101 |
| Singh AAGC, Lee D, Jeong H, et al. (2018) Tissue-engineered Neo-Urinary Conduit from Decellularized Trachea. Tissue Engineering. Part A |
| Lee D, Lu Q, Sommerfeld SD, et al. (2017) Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease. Acta Biomaterialia |
| Singh A, Lee D, Sopko N, et al. (2017) Biomanufacturing Seamless Tubular and Hollow Collagen Scaffolds with Unique Design Features and Biomechanical Properties. Advanced Healthcare Materials |
| Sadtler K, Singh A, Wolf MT, et al. (2016) Design, clinical translation and immunological response of biomaterials in regenerative medicine Nature Reviews Materials. 1 |
| Jacobs H, Rathod S, Singh A, et al. (2016) A hyaluronic acid binding peptide-polymer system for treating osteoarthritis: an in vivo study Osteoarthritis and Cartilage. 24: S435 |
| Kates M, Singh A, Matsui H, et al. (2015) Tissue-engineered urinary conduits. Current Urology Reports. 16: 8 |
| Reid B, Gibson M, Singh A, et al. (2015) PEG hydrogel degradation and the role of the surrounding tissue environment. Journal of Tissue Engineering and Regenerative Medicine. 9: 315-8 |
| Suhag D, Bhatia R, Das S, et al. (2015) Physically cross-linked pH-responsive hydrogels with tunable formulations for controlled drug delivery Rsc Advances. 5: 53963-53972 |